SERVIER (S) PTE LTD

Charity Fund is a key component of our CSR strategy, aligning with our mission to advance therapeutic progress for the benefit of patients. Through this fund, we aim to provide financial support to organizations dedicated to improving healthcare outcomes and quality of life.

As a global pharmaceutical group governed by a Foundation, Servier invests over 20% of its brand-name revenue in R&D annually to accelerate therapeutic innovation for the benefit of patients. With a strong international presence in 150 countries and a total revenue of 4.7 billion euros in 2021, Servier employs 21,800 people worldwide. The group aims to become a renowned and innovative player in oncology while maintaining its leadership in cardiology and expanding into new areas such as neuroscience and immuno-inflammatory diseases. Additionally, Servier offers a range of quality generic drugs covering most pathologies to promote access to healthcare for all.

Servier is a global pharmaceutical company founded to serve health, driven by a Foundation that aims to make a positive social impact. With a unique governance model, we prioritize therapeutic progress to serve patient needs, investing over 50% of our R&D budget in oncology and neuroscience. We offer a range of quality generic drugs and include the patient voice in our drug development process. Headquartered in France, we operate in over 150 countries and generated €4.9 billion in revenue in 2022.

Servier is a privately held international pharmaceutical company with a passion for innovation that has improved patients' lives around the world. With $4.7 billion in annual sales, Servier operates in almost 150 countries worldwide across five therapeutic categories, including oncology, cardiovascular, immuno-inflammatory, neuroscience, and diabetes. Founded on the principle of serving and governed by an independent non-profit foundation, Servier re-invests 25% of revenue into research and development each year, committing to therapeutic progress to serve patient needs and provide future generations with access to quality healthcare.